Keirsos Competitors

Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. As a global leader of innovative and comprehensive laboratory services, we help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. Our more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about Labcorp (NYSE: LH) at www.labcorp.com.

At LifeCell International, we believe healthcare should begin early, stay proactive, and evolve with life. In 2004, we began our journey as India’s first and only stem cell bank with a community banking model. As one of India’s most trusted healthcare innovators for 21 years, LifeCell now operates across five verticals: 🔬 Biobank – Preserving cord blood stem cells for future treatment of serious diseases 🧬 Biologics – Human tissue-based wound-care solutions enabling advanced healing 🌿 AreoVeda – Mom & Baby Skincare range, triple-certified safe, natural, and toxin free 📱 MFine – Best-in-class App for doctor consultations, wellbeing checks & employee health benefits. 🧪 LifeCell Diagnostics – Offers 4500+ advanced tests, 40+ accredited labs across 2500+ cities Together, these divisions form an integrated healthcare ecosystem — combining biotechnology, regenerative science, digital health, certified-safe skincare and wellness- all under one roof! LifeCell stands at the intersection of science, technology, and trust — delivering solutions that empower families today and protect generations tomorrow.

CryoLife’s mission is to partner with clinicians to restore health by delivering innovative technologies. CryoLife is one of the world’s leading medical device companies, providing preserved human tissues for cardiac and vascular surgeries, mechanical heart valves for aortic or mitral valve replacement, surgical adhesives and sealants, vascular grafts, and state-of-the-art technology and surgical training in adult and pediatric cardiovascular surgery. CryoLife is a pioneer and leader in processing, preserving and distributing human tissues, for use in cardiac and vascular surgeries. Founded in 1984, CryoLife was the first biomedical company to specialize in low temperature preservation of human heart valves used for complex cardiac reconstruction, primarily in children born with heart defects. Since the company’s inception, it is estimated that Cryolife has received tissues from over 145,000 donors and CryoLife products and tissues have been implanted in over 1 million patients worldwide. CryoLife is headquartered in Kennesaw, Georgia, with offices in Austin, Texas, Guildford, Surrey, UK, and Hechingen, Germany, as well as sales and marketing centers in Singapore, and representation in over 85 countries worldwide. The firm’s 1000+ employees hail from 11 countries and speak 17 languages. CryoLife’s staff includes numerous full-time physicians and Ph.D.s, with disciplines in chemical engineering, biomedical engineering, biochemistry, protein chemistry and organic chemistry. CryoLife is a public company and is traded on the New York Stock Exchange under the symbol CRY.